Literature DB >> 3886386

Successful transplantation of soy bean agglutinin-fractionated, histoincompatible, maternal marrow in a patient with severe combined immunodeficiency and BCG infection.

M Minegishi, S Tsuchiya, M Imaizumi, Y Yamaguchi, Y Goto, M Tamura, T Konno, K Tada.   

Abstract

A successful transplantation of soybean agglutinin (SBA) and sheep red blood cell (SRBC)-fractionated, maternal marrow in a patient with severe combined immunodeficiency (SCID) is reported. The engraftment of HLA-haplotype mismatched marrow cells was obtained without apparent graft versus host disease (GVHD). With immunological reconstitution the patient recovered from a BCG infection, which might have been caused by a BCG inoculation before his bone marrow transplantation.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3886386     DOI： 10.1007/bf00442303

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


  10 in total

Review 1.  Bone-marrow transplantation (second of two parts).

Authors:  E D Thomas; R Storb; R A Clift; A Fefer; L Johnson; P E Neiman; K G Lerner; H Glucksberg; C D Buckner
Journal:  N Engl J Med       Date:  1975-04-24       Impact factor: 91.245

2.  Cooperation between thymus and transplanted precursor cells during reconstitution of immunodeficiencies with bone marrow or fetal liver cells.

Authors:  J L Touraine
Journal:  Haematol Blood Transfus       Date:  1980

3.  Epstein-Barr virus-induced lymphoblastoid cell lines from patients with primary immunodeficiency diseases.

Authors:  S Tsuchiya; T Konno; K Tada; Y Ono
Journal:  Scand J Immunol       Date:  1980       Impact factor: 3.487

4.  T-cell subsets analyzed by monoclonal antibodies in patients with primary immunodeficiency diseases.

Authors:  M Minegishi; S Tsuchiya; M Imaizumi; Y Yamaguchi; T Konno; K Tada
Journal:  Tohoku J Exp Med       Date:  1984-03       Impact factor: 1.848

5.  Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells.

Authors:  Y Reisner; N Kapoor; D Kirkpatrick; M S Pollack; B Dupont; R A Good; R J O'Reilly
Journal:  Lancet       Date:  1981-08-15       Impact factor: 79.321

6.  OKT3 incubation of donor marrow for prophylaxis of acute graft-vs.-host disease (GvHD) in allogeneic bone marrow transplantation.

Authors:  H G Prentice
Journal:  J Clin Immunol       Date:  1982-07       Impact factor: 8.317

7.  An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction.

Authors:  H Masur; M A Michelis; J B Greene; I Onorato; R A Stouwe; R S Holzman; G Wormser; L Brettman; M Lange; H W Murray; S Cunningham-Rundles
Journal:  N Engl J Med       Date:  1981-12-10       Impact factor: 91.245

8.  Immunoreconstitution in severe combined immunodeficiency after transplantation of HLA-haploidentical, T-cell-depleted bone marrow.

Authors:  W Friedrich; S F Goldmann; U Vetter; T M Fliedner; B Heymer; H H Peter; Y Reisner; E Kleihauer
Journal:  Lancet       Date:  1984-04-07       Impact factor: 79.321

9.  Reconstitution after transplantation with T-lymphocyte-depleted HLA haplotype-mismatched bone marrow for severe combined immunodeficiency.

Authors:  E L Reinherz; R Geha; J M Rappeport; M Wilson; A C Penta; R E Hussey; K A Fitzgerald; J F Daley; H Levine; F S Rosen; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

10.  Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells.

Authors:  Y Reisner; N Kapoor; D Kirkpatrick; M S Pollack; S Cunningham-Rundles; B Dupont; M Z Hodes; R A Good; R J O'Reilly
Journal:  Blood       Date:  1983-02       Impact factor: 22.113
  10 in total
  6 in total

1.  Molecular diagnosis of severe combined immunodeficiency--identification of IL2RG, JAK3, IL7R, DCLRE1C, RAG1, and RAG2 mutations in a cohort of Chinese and Southeast Asian children.

Authors:  Pamela P W Lee; Koon-Wing Chan; Tong-Xin Chen; Li-Ping Jiang; Xiao-Chuan Wang; Hua-Song Zeng; Xiang-Yuan Chen; Woei-Kang Liew; Jing Chen; Kit-Man Chu; Lee-Lee Chan; Lynette Shek; Anselm C W Lee; Hsin-Hui Yu; Qiang Li; Chen-Guang Xu; Geraldine Sultan-Ugdoracion; Zarina Abdul Latiff; Amir Hamzah Abdul Latiff; Orathai Jirapongsananuruk; Marco H K Ho; Tsz-Leung Lee; Xi-Qiang Yang; Yu-Lung Lau
Journal:  J Clin Immunol       Date:  2010-12-24       Impact factor: 8.317

Review 2.  Bacillus Calmette-Guérin (BCG) complications associated with primary immunodeficiency diseases.

Authors:  Sayna Norouzi; Asghar Aghamohammadi; Setareh Mamishi; Sergio D Rosenzweig; Nima Rezaei
Journal:  J Infect       Date:  2012-03-16       Impact factor: 6.072

3.  The use of soybean agglutinin (SBA) for bone marrow (BM) purging and hematopoietic progenitor cell enrichment in clinical bone-marrow transplantation.

Authors:  A Nagler; S Morecki; S Slavin
Journal:  Mol Biotechnol       Date:  1999-04       Impact factor: 2.695

4.  Transplantation of human cells into Interleukin-2 receptor gamma gene knockout pigs under several conditions.

Authors:  Koki Hasegawa; Kazuaki Nakano; Masaki Nagaya; Masahito Watanabe; Ayuko Uchikura; Hitomi Matsunari; Kazuhiro Umeyama; Eiji Kobayashi; Hiroshi Nagashima
Journal:  Regen Ther       Date:  2022-06-12       Impact factor: 3.651

5.  Disseminated Bacillus Calmette-Guérin (BCG) infection following allogeneic hematopoietic stem cell transplant in a patient with Bare Lymphocyte Syndrome type II.

Authors:  R F Abu-Arja; B E Gonzalez; M R Jacobs; L Cabral; R Egler; J Auletta; J Arnold; K R Cooke
Journal:  Transpl Infect Dis       Date:  2014-07-04       Impact factor: 2.228

6.  Successful bone marrow transplantation and treatment of BCG infection in two patients with severe combined immunodeficiency.

Authors:  R S Heyderman; G Morgan; R J Levinsky; S Strobel
Journal:  Eur J Pediatr       Date:  1991-05       Impact factor: 3.183
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.